| Metabolic engineering advances and prospects for amino acid production | Metabolic Engineering | 2020 | 86 |
| Engineering biosynthesis of polyhydroxyalkanoates (PHA) for diversity and cost reduction | Metabolic Engineering | 2020 | 76 |
| Metabolic engineering for the synthesis of polyesters: A 100-year journey from polyhydroxyalkanoates to non-natural microbial polyesters | Metabolic Engineering | 2020 | 74 |
| Engineering 4-coumaroyl-CoA derived polyketide production in Yarrowia lipolytica through a β-oxidation mediated strategy | Metabolic Engineering | 2020 | 70 |
| CRISPR/Cas9 directed editing of lycopene epsilon-cyclase modulates metabolic flux for β-carotene biosynthesis in banana fruit | Metabolic Engineering | 2020 | 61 |
| The yeast peroxisome: A dynamic storage depot and subcellular factory for squalene overproduction | Metabolic Engineering | 2020 | 60 |
| Metabolic engineering for the production of dicarboxylic acids and diamines | Metabolic Engineering | 2020 | 59 |
| CRISPR-Cas12a/Cpf1-assisted precise, efficient and multiplexed genome-editing in | Metabolic Engineering Communications | 2020 | 51 |
| In vitro prototyping of limonene biosynthesis using cell-free protein synthesis | Metabolic Engineering | 2020 | 43 |
| Coupling metabolic addiction with negative autoregulation to improve strain stability and pathway yield | Metabolic Engineering | 2020 | 42 |
| Adaptive laboratory evolution of KT2440 improves -coumaric and ferulic acid catabolism and tolerance | Metabolic Engineering Communications | 2020 | 40 |
| Revisiting metabolic engineering strategies for microbial synthesis of oleochemicals | Metabolic Engineering | 2020 | 40 |
| Development of both type I-B and type II CRISPR/Cas genome editing systems in the cellulolytic bacterium | Metabolic Engineering Communications | 2020 | 38 |
| Modular engineering for microbial production of carotenoids | Metabolic Engineering Communications | 2020 | 38 |
| Debottlenecking mevalonate pathway for antimalarial drug precursor amorphadiene biosynthesis in | Metabolic Engineering Communications | 2020 | 38 |
| Total in vitro biosynthesis of the nonribosomal macrolactone peptide valinomycin | Metabolic Engineering | 2020 | 35 |
| Building microbial factories for the production of aromatic amino acid pathway derivatives: From commodity chemicals to plant-sourced natural products | Metabolic Engineering | 2020 | 34 |
| Engineering glucose metabolism for enhanced muconic acid production in Pseudomonas putida KT2440 | Metabolic Engineering | 2020 | 33 |
| Enhancing isoprenoid synthesis in Yarrowia lipolytica by expressing the isopentenol utilization pathway and modulating intracellular hydrophobicity | Metabolic Engineering | 2020 | 33 |
| Replacing the Calvin cycle with the reductive glycine pathway in Cupriavidus necator | Metabolic Engineering | 2020 | 31 |
| A CRISPR/Cas9-based genome editing system for Rhodococcus ruber TH | Metabolic Engineering | 2020 | 31 |
| Engineering chimeric diterpene synthases and isoprenoid biosynthetic pathways enables high-level production of miltiradiene in yeast | Metabolic Engineering | 2020 | 30 |
| A single-host fermentation process for the production of flavor lactones from non-hydroxylated fatty acids | Metabolic Engineering | 2020 | 30 |
| Engineering the oleaginous yeast Yarrowia lipolytica for high-level resveratrol production | Metabolic Engineering | 2020 | 29 |
| Metabolic engineering of Saccharomyces cerevisiae for the de novo production of psilocybin and related tryptamine derivatives | Metabolic Engineering | 2020 | 27 |
